No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
Tassilo SchieblerIvayla ApostolovaFranziska Lara MathiesCatharina LangeSusanne KlutmannRalph BuchertPublished in: European journal of nuclear medicine and molecular imaging (2023)
Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome.